Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rule-Based Ion Prediction with Orthogonal Constraints Reveals Bacterial Phospholipid Remodeling Signatures.

Antibiotics (Basel, Switzerland)·2026
Same author

Emergence of <i>tet</i>(X4)-positive <i>Klebsiella</i> isolates from aquatic products in Hainan, China.

Antimicrobial agents and chemotherapy·2026
Same author

Dietary <i>Bacillus subtilis</i> Group Reduces the General Infection of <i>Salmonella</i> Pullorum in Broiler Chicken.

Antibiotics (Basel, Switzerland)·2026
Same author

A luminescent antibacterial compound targeting Gram-negative bacterial membranes.

Biomaterials science·2026
Same author

High Stability and Low Irritation of Enrofloxacin-Colistin Combination Injection Through a Tripartite Strategy.

Drug design, development and therapy·2025
Same author

<i>Bacillus</i> spp. Potentiate the Virulence and Intracellular Invasion of <i>A. paragallinarum</i> in Chickens.

Animals : an open access journal from MDPI·2025

Related Experiment Video

Updated: Jun 11, 2025

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
10:00

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Published on: May 5, 2016

13.1K

A Rhein-Based Derivative Targets Staphylococcus aureus.

Xiaojia Liu1, Yuan Liu1, Meirong Song1

  • 1National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, No. 2 Yuanmingyuan West Road, Beijing 100193, China.

Antibiotics (Basel, Switzerland)
|September 28, 2024
PubMed
Summary

A new rhein-derived compound, RH17, shows strong antibacterial activity against Staphylococcus aureus. This novel agent disrupts bacterial membranes and increases reactive oxygen species, offering a promising solution for antibiotic resistance.

Keywords:
Gram-positive pathogenanthraquinone derivativesmembrane targetrhein

More Related Videos

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

6.3K
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

2.7K

Related Experiment Videos

Last Updated: Jun 11, 2025

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
10:00

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Published on: May 5, 2016

13.1K
Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

6.3K
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

2.7K

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Drug Discovery

Background:

  • Antibiotic resistance is a growing global health threat, necessitating the development of new antimicrobial drugs.
  • Rhein (RH) is a natural compound with potential antimicrobial properties, but its efficacy needs enhancement.

Purpose of the Study:

  • To design and synthesize novel rhein-derived compounds with improved antimicrobial activity.
  • To evaluate the antibacterial efficacy and mechanism of action of the lead compound, RH17, against Staphylococcus aureus.

Main Methods:

  • Synthesis of a series of rhein-derived compounds.
  • Determination of minimum inhibitory concentrations (MICs) against Staphylococcus aureus isolates.
  • Assessment of bacterial membrane stability, metabolic processes, and reactive oxygen species (ROS) production.

Main Results:

  • The lead compound, RH17, demonstrated potent antibacterial activity against Staphylococcus aureus, with MICs of 8-16 μg/mL.
  • RH17 disrupted bacterial membrane integrity and inhibited metabolic functions.
  • RH17 induced a significant increase in reactive oxygen species (ROS) production in bacteria.

Conclusions:

  • RH17 exhibits significant antimicrobial potential against Gram-positive pathogens like Staphylococcus aureus.
  • The compound's mechanism involves membrane disruption and ROS generation, offering a novel approach to combat resistant bacteria.
  • RH17 represents a promising lead for developing new antimicrobial therapies to address the challenge of antibiotic resistance.